Nexstim Oyj (NXTMH) - Total Assets
Based on the latest financial reports, Nexstim Oyj (NXTMH) holds total assets worth €12.35 Million EUR (≈ $14.44 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See NXTMH net asset value for net asset value and shareholders' equity analysis.
Nexstim Oyj - Total Assets Trend (2012–2024)
This chart illustrates how Nexstim Oyj's total assets have evolved over time, based on quarterly financial data.
Nexstim Oyj - Asset Composition Analysis
Current Asset Composition (December 2024)
Nexstim Oyj's total assets of €12.35 Million consist of 63.6% current assets and 36.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 27.2% |
| Accounts Receivable | €4.03 Million | 28.4% |
| Inventory | €814.51K | 5.7% |
| Property, Plant & Equipment | €358.42K | 2.5% |
| Intangible Assets | €3.77 Million | 26.6% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Nexstim Oyj's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see NXTMH company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nexstim Oyj's current assets represent 63.6% of total assets in 2024, a decrease from 87.5% in 2012.
- Cash Position: Cash and equivalents constituted 27.2% of total assets in 2024, down from 49.3% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 26.0% of total assets, an increase from 10.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 28.4% of total assets.
Nexstim Oyj Competitors by Total Assets
Key competitors of Nexstim Oyj based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥965.27 Million |
|
Shanghai Kinetic Medical Co
SHE:300326
|
China | CN¥3.38 Billion |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
|
China | CN¥3.54 Billion |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
|
China | CN¥1.86 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $74.23 Million |
Nexstim Oyj - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.25 | 1.49 | 2.61 |
| Quick Ratio | 1.08 | 1.24 | 2.36 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €1.37 Million | €2.21 Million | €3.94 Million |
Nexstim Oyj - Advanced Valuation Insights
This section examines the relationship between Nexstim Oyj's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 33.47 |
| Latest Market Cap to Assets Ratio | 5.15 |
| Asset Growth Rate (YoY) | 43.7% |
| Total Assets | €14.20 Million |
| Market Capitalization | $73.20 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Nexstim Oyj's assets at a significant premium (5.15x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Nexstim Oyj's assets grew by 43.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Nexstim Oyj (2012–2024)
The table below shows the annual total assets of Nexstim Oyj from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €14.20 Million ≈ $16.60 Million |
+43.71% |
| 2023-12-31 | €9.88 Million ≈ $11.55 Million |
-3.25% |
| 2022-12-31 | €10.21 Million ≈ $11.94 Million |
+1.74% |
| 2021-12-31 | €10.04 Million ≈ $11.74 Million |
+61.12% |
| 2020-12-31 | €6.23 Million ≈ $7.29 Million |
-18.59% |
| 2019-12-31 | €7.65 Million ≈ $8.95 Million |
-20.78% |
| 2018-12-31 | €9.66 Million ≈ $11.30 Million |
-12.51% |
| 2017-12-31 | €11.04 Million ≈ $12.91 Million |
+6.01% |
| 2016-12-31 | €10.42 Million ≈ $12.18 Million |
+13.15% |
| 2015-12-31 | €9.21 Million ≈ $10.76 Million |
-34.21% |
| 2014-12-31 | €13.99 Million ≈ $16.36 Million |
+359.20% |
| 2013-12-31 | €3.05 Million ≈ $3.56 Million |
-23.10% |
| 2012-12-31 | €3.96 Million ≈ $4.63 Million |
-- |
About Nexstim Oyj
Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique whereby pulses of electromagnetic fields target and interact with specific brain regions from outside the head. It provi… Read more